Regulon

Regulon: R-1182

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
18-1.2834610Pr-134Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
9733 ENSG00000075856 SART3 Q15020
54665 ENSG00000081019 RSBN1 Q5VWQ0
51729 ENSG00000084463 WBP11 Q9Y2W2
11198 ENSG00000092201 SUPT16H Q9Y5B9
10240 ENSG00000102738 MRPS31 Q92665
10664 ENSG00000102974 CTCF P49711
55188 ENSG00000111785 RIC8B A0A024RBG9
10274 ENSG00000118007 STAG1 Q8WVM7
6418 ENSG00000119335 SET Q01105
5894 ENSG00000132155 RAF1 A0A8I5KR46
142 ENSG00000143799 PARP1 P09874
51631 ENSG00000146963 LUC7L2 Q9Y383
5529 ENSG00000154001 PPP2R5E Q16537
65110 ENSG00000169062 UPF3A Q9H1J1
5747 ENSG00000169398 PTK2 E5RH01
171023 ENSG00000171456 ASXL1 Q8IXJ9
30849 ENSG00000196455 PIK3R4 Q99570
23054 ENSG00000198646 NCOA6 Q14686

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
RUCAPARIBPARP1Small moleculeINHIBITORPARP 1, 2 and 3 inhibitor40
PAMIPARIBPARP1Small moleculeINHIBITORPoly [ADP-ribose] polymerase-1 inhibitor31
XL-281RAF1Small moleculeINHIBITORSerine/threonine-protein kinase RAF inhibitor20
GSK-2256098PTK2Small moleculeINHIBITORFocal adhesion kinase 1 inhibitor20
SORAFENIB TOSYLATEPDGFRBSmall moleculeINHIBITORStem cell growth factor receptor inhibitor42
BI-853520PTK2Small moleculeINHIBITORFocal adhesion kinase 1 inhibitor10
MLN-2480RAF1Small moleculeINHIBITORRAF serine/threonine protein kinase inhibitor10
OLAPARIBPARP1Small moleculeINHIBITORPARP 1, 2 and 3 inhibitor42
SORAFENIBFLT3Small moleculeINHIBITORStem cell growth factor receptor inhibitor42
TALAZOPARIBPARP1Small moleculeINHIBITORPoly [ADP-ribose] polymerase 2 inhibitor42
VS-4718PTK2Small moleculeINHIBITORFocal adhesion kinase 1 inhibitor10
DEFACTINIBPTK2BSmall moleculeINHIBITORFocal adhesion kinase 1 inhibitor20
RUCAPARIB CAMSYLATEPARP1Small moleculeINHIBITORPARP 1, 2 and 3 inhibitor40
VELIPARIBPARP1Small moleculeINHIBITORPARP 1, 2 and 3 inhibitor32
ARQ-736RAF1Small moleculeINHIBITORSerine/threonine-protein kinase RAF inhibitor10
2X-121TNKS2Small moleculeINHIBITORPoly [ADP-ribose] polymerase-1 inhibitor20
NIRAPARIBPARP2Small moleculeINHIBITORPoly [ADP-ribose] polymerase 2 inhibitor42
LY-3009120ARAFSmall moleculeINHIBITORSerine/threonine-protein kinase A-Raf inhibitor10
LXH254RAF1Small moleculeINHIBITORB-raf/RAF proto-oncogene serine/threonine-protein kinase inhibitor20
NIRAPARIB TOSYLATEPARP1Small moleculeINHIBITORPoly [ADP-ribose] polymerase 2 inhibitor40
CEP-37440ALKSmall moleculeINHIBITORFocal adhesion kinase 1 inhibitor10
TALAZOPARIB TOSYLATEPARP1Small moleculeINHIBITORPoly [ADP-ribose] polymerase 2 inhibitor40
REGORAFENIBKDRSmall moleculeINHIBITORTyrosine-protein kinase TIE-2 inhibitor42
CONTELTINIBPTK2Small moleculeINHIBITORProtein tyrosine kinase 2 beta inhibitor10
BELVARAFENIBRAF1Small moleculeINHIBITORRAF serine/threonine protein kinase inhibitor20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1182

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs